Examining genetic susceptibility in acute exacerbations of COPD

Thorax

Volumn 73, Issue 6, 2018, Pages 507-509

  Wan, Emily S ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VA Boston Health Care System Jamaica Plain Campus ^*  (United States)

Author keywords

COPD exacerbations

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; MANNOSE BINDING LECTIN 2; TRANSFORMING GROWTH FACTOR BETA2; MANNOSE BINDING LECTIN;

ARDB2 GENE; BACTERIAL COLONIZATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; GENE SEQUENCE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAEMOPHILUS; HUMAN; MBL2 GENE; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; POPULATION STRUCTURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPIROMETRY; TGFB2 GENE; GENETIC PREDISPOSITION; INBORN ERROR OF METABOLISM; MICROFLORA;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; MANNOSE-BINDING LECTIN; METABOLISM, INBORN ERRORS; MICROBIOTA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 85050985500     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2017-211106     Document Type: Review

References (24)

1. Punekar YS, Shukla A, Mullerova H. COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis 2014;9:65-73
2. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38
3. Tran HB, Ahern J, Hodge G, et al. Oxidative stress decreases functional airway mannose binding lectin in COPD. PLoS One 2014;9:e98571
4. Lin CL, Siu LK, Lin JC, et al. Mannose-binding lectin gene polymorphism contributes to recurrence of infective exacerbation in patients with COPD. Chest 2011;139:43-51
5. Mandal J, Malla B, Steffensen R, et al. Mannosebinding lectin protein and its association to clinical outcomes in COPD: a longitudinal study. Respir Res 2015;16:150
6. Yang IA, Seeney SL, Wolter JM, et al. Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections. Genes Immun 2003;4:269-74
7. Albert RK, Connett J, Curtis JL, et al. Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2012;7:767-77
8. Eagan TM, Aukrust P, Bakke PS, et al. Systemic mannose-binding lectin is not associated with Chronic Obstructive Pulmonary Disease. Respir Med 2010;104:283-90
9. Dicker AJ, Crichton ML, Cassidy AJ, et al. Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD. Thorax 2018;73:510-8
10. Mlak R, Homa-Mlak I, Powrozek T, et al. Impact of I/D polymorphism of ACE gene on risk of development and course of chronic obstructive pulmonary disease. Arch Med Sci 2016;12:279-87
11. Rabe KF, Fabbri LM, Israel E, et al. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial. Lancet Respir Med 2014;2:44-53
12. Vacca G, Schwabe K, Duck R, et al. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease. Ther Adv Respir Dis 2009;3:3-10
13. Emeryk-Maksymiuk J, Emeryk A, Krawczyk P, et al. Beta-2-Adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2017;43:1-5
14. Zhang JQ, Zhang JQ, Liu H, et al. Effect of N-Acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes. Int J Chron Obstruct Pulmon Dis 2015;10:917-23
15. Plate M, Lawson PJ, Hill MR, et al. Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbations. Am J Physiol Lung Cell Mol Physiol 2014;307:L311-16
16. Ishii T, Motegi T, Kamio K, et al. Association of group component genetic variations in COPD and COPD exacerbation in a Japanese population. Respirology 2014;19:590-5
17. Zhang JQ, Zhang JQ, Fang LZ, et al. Effect of oral N-Acetylcysteine on COPD patients with microsatellite polymorphism in the heme oxygenase-1 gene promoter. Drug Des Devel Ther 2015;9:6379-87
18. Schwabe K, Vacca G, Duck R, et al. Glucocorticoid receptor gene polymorphisms and potential association to chronic obstructive pulmonary disease susceptibility and severity. Eur J Med Res 2009;14(Suppl 4):210-5
19. Ishii T, Angata T, Wan ES, et al. Influence of SIGLEC9 polymorphisms on COPD phenotypes including exacerbation frequency. Respirology 2017;22:684-90
20. Angata T, Ishii T, Motegi T, et al. Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation. Cell Mol Life Sci 2013;70:3199-210
21. Quint JK, Donaldson GC, Kumari M, et al. SERPINA1 11478G?A variant, serum ?1-Antitrypsin, exacerbation frequency and FEV1 decline in COPD. Thorax 2011;66:418-24
22. Foreman MG, DeMeo DL, Hersh CP, et al. Polymorphic variation in surfactant protein B is associated with COPD exacerbations. Eur Respir J 2008;32:938-44
23. Ou CY, Chen CZ, Hsiue TR, et al. Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population. Respirology 2015;20:296-303
24. Ozdoan N, Tutar N, Demir R, et al. Is TNF-?. gene polymorphism related to pulmonary functions and prognosis as determined by FEV1, BMI, COPD exacerbation and hospitalization in patients with smoking-related COPD in a Turkish population?. Rev Port Pneumol 2014;20:305-10.